News Digest / Ticker: HRTX

Ticker: HRTX

08:01am, Friday, Aug 08, 2025

Heron Therapeutics Reports Q2 2025 Growth Amid Ongoing Challenges and Increased Debt Concerns

Heron Therapeutics, Inc. (NASDAQ: HRTX) - Q2 2025 Overview Heron Therapeutics focuses on improving patient outcomes through innovative medicines, particularly in managing pain and nausea associated with surgeries and chemotherapy. The company has recently reported its Q2 2025 earnings, highlighti...

08:01am, Tuesday, May 06, 2025

Heron Therapeutics Posts Q1 2025 Profit Amid Revenue Growth and Legal Challenges Ahead